HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Antithrombin up-regulates AMP-activated protein kinase signalling during myocardial ischaemia/reperfusion injury.

Abstract
Antithrombin (AT) is a protein of the serpin superfamily involved in regulation of the proteolytic activity of the serine proteases of the coagulation system. AT is known to exhibit anti-inflammatory and cardioprotective properties when it binds to heparan sulfate proteoglycans (HSPGs) on vascular cells. AMP-activated protein kinase (AMPK) plays an important cardioprotective role during myocardial ischaemia and reperfusion (I/R). To determine whether the cardioprotective signaling function of AT is mediated through the AMPK pathway, we evaluated the cardioprotective activities of wild-type AT and its two derivatives, one having high affinity and the other no affinity for heparin, in an acute I/R injury model in C57BL/6J mice in which the left anterior descending coronary artery was occluded. The serpin derivatives were given 5 minutes before reperfusion. The results showed that AT-WT can activate AMPK in both in vivo and ex vivo conditions. Blocking AMPK activity abolished the cardioprotective function of AT against I/R injury. The AT derivative having high affinity for heparin was more effective in activating AMPK and in limiting infraction, but the derivative lacking affinity for heparin was inactive in eliciting AMPK-dependent cardioprotective activity. Activation of AMPK by AT inhibited the inflammatory c-Jun N-terminal protein kinase (JNK) pathway during I/R. Further studies revealed that the AMPK activity induced by AT also modulates cardiac substrate metabolism by increasing glucose oxidation but inhibiting fatty acid oxidation during I/R. These results suggest that AT binds to HSPGs on heart tissues to invoke a cardioprotective function by triggering cardiac AMPK activation, thereby attenuating JNK inflammatory signalling pathways and modulating substrate metabolism during I/R.
AuthorsYina Ma, Jinli Wang, Junjie Gao, Hui Yang, Yanqing Wang, Chandrashekhara Manithody, Ji Li, Alireza R Rezaie
JournalThrombosis and haemostasis (Thromb Haemost) Vol. 113 Issue 2 Pg. 338-49 (Feb 2015) ISSN: 2567-689X [Electronic] Germany
PMID25230600 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Anticoagulants
  • Antithrombins
  • Cardiotonic Agents
  • Fatty Acids
  • Heparin
  • AMP-Activated Protein Kinases
  • Glucose
  • Oxygen
Topics
  • AMP-Activated Protein Kinases (metabolism)
  • Animals
  • Anticoagulants (chemistry)
  • Antithrombins (chemistry)
  • Cardiotonic Agents (chemistry)
  • Fatty Acids (chemistry)
  • Glucose (chemistry)
  • Heart (physiology)
  • Heparin (chemistry)
  • Human Umbilical Vein Endothelial Cells
  • Humans
  • Inflammation
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Myocardial Infarction (pathology)
  • Myocardial Ischemia (pathology)
  • Myocardial Reperfusion Injury (pathology)
  • Oxygen (chemistry)
  • Permeability
  • Phenotype
  • Signal Transduction
  • Up-Regulation

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: